Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Intensive Care Med ; 46(2): 298-314, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-32034433

RESUMO

An increasing number of critically ill patients are immunocompromised. Acute hypoxemic respiratory failure (ARF), chiefly due to pulmonary infection, is the leading reason for ICU admission. Identifying the cause of ARF increases the chances of survival, but may be extremely challenging, as the underlying disease, treatments, and infection combine to create complex clinical pictures. In addition, there may be more than one infectious agent, and the pulmonary manifestations may be related to both infectious and non-infectious insults. Clinically or microbiologically documented bacterial pneumonia accounts for one-third of cases of ARF in immunocompromised patients. Early antibiotic therapy is recommended but decreases the chances of identifying the causative organism(s) to about 50%. Viruses are the second most common cause of severe respiratory infections. Positive tests for a virus in respiratory samples do not necessarily indicate a role for the virus in the current acute illness. Invasive fungal infections (Aspergillus, Mucorales, and Pneumocystis jirovecii) account for about 15% of severe respiratory infections, whereas parasites rarely cause severe acute infections in immunocompromised patients. This review focuses on the diagnosis of severe respiratory infections in immunocompromised patients. Special attention is given to newly validated diagnostic tests designed to be used on non-invasive samples or bronchoalveolar lavage fluid and capable of increasing the likelihood of an early etiological diagnosis.


Assuntos
Hospedeiro Imunocomprometido/imunologia , Infecções Respiratórias/diagnóstico , Humanos , Hospedeiro Imunocomprometido/efeitos dos fármacos , Unidades de Terapia Intensiva/organização & administração , Infecções Fúngicas Invasivas/complicações , Infecções Fúngicas Invasivas/fisiopatologia , Doenças Parasitárias/complicações , Doenças Parasitárias/fisiopatologia , Pneumonia Bacteriana/etiologia , Pneumonia Bacteriana/fisiopatologia , Insuficiência Respiratória/etiologia , Insuficiência Respiratória/fisiopatologia , Infecções Respiratórias/etiologia , Infecções Respiratórias/fisiopatologia
3.
Crit Care ; 19: 114, 2015 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-25880421

RESUMO

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/annualupdate2015. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901.


Assuntos
Infecções Bacterianas/prevenção & controle , Farmacorresistência Bacteriana Múltipla , Controle de Infecções , Unidades de Terapia Intensiva , Infecções Bacterianas/microbiologia , Bactérias Gram-Negativas , Humanos , Desenvolvimento de Programas , Fatores de Risco , Espanha
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA